The U.S. Food and Drug Administration (FDA) has announced that Dexcom, a leader in continuous glucose monitoring, will be the inaugural participant in its Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot program. This initiative, introduced by the Trump administration, aims to assess the efficacy of digital health technologies in managing chronic diseases while simultaneously collecting real-world evidence.
The TEMPO pilot operates alongside the FDA's ACCESS model, which offers a new regulatory framework for certain digital health devices intended for chronic disease management. The ACCESS model launched earlier this month and is designed to deliver a consistent reimbursement structure for technologies treating conditions such as diabetes, hypertension, and chronic kidney disease that meet specific clinical benchmarks.
Under the TEMPO framework, Dexcom plans to leverage its AI-powered glucose health program. This program integrates data from the Dexcom G7 continuous glucose monitor and Stelo, enriching it with contextual information including nutrition, activity levels, sleep patterns, and stress metrics. The goal is to provide tailored insights to healthcare providers and eligible users, potentially aiding in the early screening for prediabetes and Type 2 diabetes.
Dexcom's efforts are focused on generating real-world evidence that will demonstrate how their glucose monitoring and AI-driven health programs may enhance intervention strategies and contribute to better cardiometabolic health outcomes. Jake Leach, president and CEO of Dexcom, emphasized the transformative potential of utilizing this data for personalized, preventive care that can help avert disease development.
The FDA anticipates inducting approximately ten participants into the TEMPO pilot across four clinical use categories, aiming to reflect a diverse array of manufacturers. This initiative will enhance the FDA and CMS's understanding of how digital health technologies perform in real-world situations, particularly concerning chronic disease management.
In a significant milestone, Ardent Health has reported that its Ambience AI platform has facilitated over 1 million patient encounters. This cutting-edge technology is deployed by clinicians across various specialties, achieving an impressive usage rate of 87% for ambulatory encounters, which notably surpasses the industry average of 40% to 45%.
Launched enterprise-wide in September, Ambience AI not only streamlines clinical workflows but also significantly reduces the administrative burden on healthcare providers. Executives from Ardent Health indicated that the platform allows providers to save over three hours each week on documentation tasks, as evidenced by data from electronic health records (EHR).
Dr. Brad Hoyt, Chief Medical Information Officer at Ardent Health, remarked that this achievement reflects the commitment of physicians and advanced practice providers who are utilizing the technology to strengthen patient connections. Enhanced patient-provider interactions can significantly combat clinician burnout and allow providers to dedicate more time to patient care.
Example testimonials illustrate the benefits of using Ambience AI. Dr. Jennie Zheng, a family medicine physician, reported a 53% reduction in documentation time per clinic session after adopting the technology, freeing her to focus more on listening to her patients and engaging with them, which is especially crucial in building trust in healthcare settings.
In addition to these developments, Thrive Mobile has partnered with HealthEx to enhance access to health records for underserved Americans. This partnership will facilitate direct access to medical records via smartphones, empowering users with the ability to securely manage their health information.
VitVio also announced the launch of its 3D-native AI operating room intelligence platform, named Vetro, for hospitals worldwide. This innovative solution ensures real-time monitoring and management of surgical environments, aiming to improve patient outcomes.
Lastly, AdvancedMD has expanded its AI-powered revenue cycle management capabilities, providing tools to streamline financial processes for independent medical practices, thereby enhancing their operational efficiency.
The introduction of the TEMPO pilot featuring Dexcom highlights a strategic approach to innovative digital health solutions, while Ardent Health's achievement with ambient AI underscores the transformative power of technology in clinical practice. As partnerships and technological advancements continue to unfold, they promise to enhance patient care and improve outcomes in the healthcare landscape.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.